PUBLISHER: Grand View Research | PRODUCT CODE: 1751504
PUBLISHER: Grand View Research | PRODUCT CODE: 1751504
The global atmospheric plasma technology market size is anticipated to reach USD 3,398.3 million by 2030 and is projected to grow at a CAGR of 6.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The atmospheric plasma technology industry is expanding rapidly, driven by growing demand for environmentally friendly surface treatment across sectors such as electronics, automotive, and healthcare. Its capability to improve adhesion, cleaning, and sterilization without chemicals combined with advancements in cold plasma and automation is accelerating its adoption and contributing to market growth.
Market opportunities in the atmospheric plasma technology industry are expanding rapidly across multiple industries. Miniaturization in electronics offers a major opportunity for the market. As devices become more compact and complex, manufacturers require highly precise, non-damaging surface treatment solutions. Atmospheric plasma provides consistent cleaning and activation without excessive heat or harsh chemicals, making it ideal for delicate components like microchips, thus boosting its use in advanced electronics production.
Regulatory pressures play a crucial role in shaping the atmospheric plasma technology industry by enforcing standards that drive innovation and compliance.In the U.S., the FDA enforces rigorous approval processes for plasma-based medical devices and treatments to ensure safety and efficacy. In Europe, CE marking is essential for market entry, indicating adherence to EU health and safety standards. Regulations like REACH and RoHS control chemical use and hazardous materials, influencing the development of cleaner, compliant plasma technologies. Together, these frameworks drive innovation, regulatory compliance, and industry-wide market access.
Top players in the atmospheric plasma technology industry, such as Plasmatreat, OC Oerlikon Management AG, andrelyon plasma GmbH are focusing on innovation and expanding their product offerings to cater to different industries. These companies are investing in research and development to introduce advanced atmospheric plasma technology. Strategic acquisitions and partnerships with manufacturers and retailers also help these players expand their market reach. For instance, in February 2025 Viromed Medical AG collaborated with a multinational corporation, securing a European license for the use of cold atmospheric pressure plasma in medicine.